Trials / Terminated
TerminatedNCT04902651
HM242-Gel vs Comparator
A PROSPECTIVE, CONTROLLED, RANDOMIZED, OPEN-LABEL PREMARKET MULTICENTER STUDY OF THE PERFORMANCE OF THE HM242-GEL VS COMPARATOR IN PATIENTS UNDER THE CONDITION OF VENOUS LEG ULCER
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 73 (actual)
- Sponsor
- B. Braun Ltd. Centre of Excellence Infection Control · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the study is to demonstrate that the HM242-Gel performs at least comparably to INTRASITE Gel with regard to wound healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HM242-Gel | HM242-Gel compared to Intrasite Gel in patients with a venous leg ulcer |
| DEVICE | Intrasite Gel | HM242-Gel compared to Intrasite Gel in patients with a venous leg ulcer |
Timeline
- Start date
- 2021-05-21
- Primary completion
- 2022-01-05
- Completion
- 2022-02-16
- First posted
- 2021-05-26
- Last updated
- 2022-07-19
Locations
3 sites across 2 countries: Czechia, Slovakia
Source: ClinicalTrials.gov record NCT04902651. Inclusion in this directory is not an endorsement.